A Philadelphia jury has awarded $2.5 million to the plaintiff in the first of roughly 1,250 Risperdal mass-tort cases in the city’s courts.
After roughly a day-and-a-half of deliberations, the 12-member jury in Pledger v. Janssen Pharmaceuticals handed down the verdict in Philadelphia Court of Common Pleas Judge Ramy I. Djerassi’s courtroom Tuesday afternoon. The verdict, agreed upon by 11 of the jurors, brought an end to the month-long trial.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
